Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
80%(4 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_3
4
67%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Other(1)

Detailed Status

Completed5
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 34 (66.7%)

Trials by Status

unknown117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

NCT00703781
completedphase_3

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

NCT01367249
completedphase_3

Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

NCT00333918
completedphase_2

Efficacy and Safety of Bromfenac Ophthalmic Solution

NCT00585975
completedphase_3

Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

NCT00853970
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00703781Phase 3

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

Completed
NCT01367249Phase 3

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Completed
NCT00333918Phase 3

Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

Completed
NCT00585975Phase 2

Efficacy and Safety of Bromfenac Ophthalmic Solution

Completed
NCT00853970Phase 3

Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Completed
NCT00491166Phase 1

Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6